Dr. Bohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Palo Alto, CA 94304Phone+1 650-723-7621
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1999 - 2001
- University of California San Francisco School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 1999 - 2025
Publications & Presentations
PubMed
- 136 citationsDose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroidsMichael Noonan, Phillip E. Korenblat, Sofia Mosesova, Heleen Scheerens, Joseph R. Arron
The Journal of Allergy and Clinical Immunology. 2013-09-01 - 1172 citationsLebrikizumab Treatment in Adults with AsthmaJonathan Corren, Robert F. Lemanske, Nicola A. Hanania, Phillip E. Korenblat, Merdad V. Parsey
The New England Journal of Medicine. 2011-09-21 - 16 citationsExpression profiles of adult T-cell leukemia–lymphoma and associations with clinical responses to zidovudine and interferon αAsh A. Alizadeh, Sean P. Bohen, Chen Lossos, Jose A. Martinez-Climent, Juan Carlos Ramos
Leukemia & Lymphoma. 2010-06-24
Press Mentions
- Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer SymposiumDecember 10th, 2024
- Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 StudyMay 11th, 2023
- Olema Plans Pivotal Trial for Two-Prong Breast Cancer TreatmentJanuary 5th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: